Skip to content
  • Tuesday, 30 June 2026
  • 2:36 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Merck KGaA and Remepy Forge Groundbreaking Partnership to Pioneer "Hybrid Drugs" for Rare Cancers
Pharmaceutical R&D

Merck KGaA and Remepy Forge Groundbreaking Partnership to Pioneer "Hybrid Drugs" for Rare Cancers

Teuku Ryan Apr 28, 2026 0

In a move that signals a significant shift in pharmaceutical innovation, Merck KGaA has announced a strategic collaboration with Remepy,…

Read More
Pharmaceutical R&D

Merck KGaA Acquires JSR Life Sciences’ Chromatography Business to Bolster Biopharmaceutical Purification Capabilities

Teuku Ryan Apr 3, 2026 0

Germany-based Merck KGaA, a leading science and technology company, has officially completed its previously announced acquisition of the chromatography business…

Read More
Probiotic Yogurt Strain May Boost Immunotherapy Response in Lung Cancer, Small Study SuggestsRoche and C4 Therapeutics Forge Strategic Alliance to Pioneer Degrader-Antibody Conjugates for Novel Cancer TherapiesValidated monospecific recombinant and monoclonal antibodiesUnlocking the Secrets of Red Lettuce Pigmentation: Researchers Engineer Novel Flavonoid Profiles Through Gene Editing
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveHigh-Dimensional Topological Structures Discovered in Entangled Photons Offer New Framework for Quantum Information StabilityWater-in-Diesel Emulsion Technology Offers Significant Emissions Reduction Potential Without Engine Modification
The Genetic Legacy of Paternal Aging: How Intra-Testicular Selection Drives Disease-Causing Mutations in SpermPens to pills: what oral GLP-1s change at the benchArc Protein Identified as Key Driver in the Spread of Toxic Tau Proteins in Alzheimer’s DiseaseTalawar Therapeutics and JATT II Acquisition Complete Business Combination to Advance Novel Immunology Therapeutics
YOU MAY HAVE MISSED
Stem Cell & Regenerative Medicine
The Genetic Legacy of Paternal Aging: How Intra-Testicular Selection Drives Disease-Causing Mutations in Sperm
Dwi Wanna Jun 30, 2026
Laboratory Automation & Robotics
Pens to pills: what oral GLP-1s change at the bench
Lana Keisha Jun 30, 2026
Neuroscience & Brain Research
Arc Protein Identified as Key Driver in the Spread of Toxic Tau Proteins in Alzheimer’s Disease
Rifan Muazin Jun 30, 2026
Pharmaceutical R&D
Talawar Therapeutics and JATT II Acquisition Complete Business Combination to Advance Novel Immunology Therapeutics
Teuku Ryan Jun 30, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ